Literature DB >> 29571875

Familial and sporadic chronic progressive degenerative parietal ataxia.

Ryuta Morihara1, Toru Yamashita1, Kentaro Deguchi1, Tomoko Kurata1, Emi Nomura1, Kota Sato1, Yumiko Nakano1, Yasuyuki Ohta1, Nozomi Hishikawa1, Takeshi Ikeuchi2, Masataka Kitaguchi3, Koji Abe4.   

Abstract

BACKGROUND &
OBJECTIVE: Parietal ataxia has been mainly reported as a consequence of acute ischemic stroke, while degenerative parietal ataxia has not been reported.
METHODS: We investigated clinical characteristics, neuroimaging data, and genetic analysis of patients with cerebellar ataxia plus parietal atrophy.
RESULTS: We identified seven patients, including five patients from two families, with chronic progressive cerebellar ataxia due to degenerative parietal atrophy but not stroke. Age at onset of ataxia was 57.6 ± 6.9 years. All patients showed chronic progressive cerebellar ataxia with severity of ataxic gait > limb ataxia > dysarthria. Patients showed no cognitive dysfunction, muscle weakness, or parkinsonism, and only two patients showed mild sensory disturbances. The seven patients showed lateralized limb ataxia with greater contralateral parietal lobe atrophy by magnetic resonance imaging, and hypoperfusion by single photon emission computed tomography, without any abnormal cerebellar pathology (i.e., crossed cerebellar diaschisis). Pathogenic mutations in the microtubule-associated protein tau gene were not found using two single nucleotide polymorphisms.
CONCLUSIONS: This is the first description showing unique clinical features of familial and sporadic chronic progressive degenerative parietal ataxia.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crossed cerebellar diaschisis; MAPT; Parietal ataxia; Parietal lobe atrophy

Mesh:

Substances:

Year:  2018        PMID: 29571875     DOI: 10.1016/j.jns.2018.01.031

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34.

Authors:  Marie Beaudin; Leila Sellami; Christian Martel; Lydia Touzel-Deschênes; Gabrielle Houle; Laurence Martineau; Kevin Lacroix; Andréane Lavallée; Nicolas Chrestian; Guy A Rouleau; François Gros-Louis; Robert Laforce; Nicolas Dupré
Journal:  Neurol Genet       Date:  2020-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.